FDA
-
-
-
-
-
-
-
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
-
-
-
-
-
-
-
AZTR receives second NYSE American non-compliance notice over equity rules
-
-
-
-
-
-
-
Azitra gets NYSE American approval for compliance plan
-
-
-
-
-
-
-
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit
-
-
-
-
-
-
-
Azitra, Inc. Announces Reverse Stock Split
-
-
-
-
-
-
-
Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025
-
-
-
-
-
-
-
Azitra, Inc. to Present at the BIO CEO & Investor Conference
-
326,678 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

